Company finished internal review on option grants which have been an overhang on the stock. Will be viewed as a relief and should cause the stock to rally, although informal SEC review could pose a continued risk. Company is reporting earnings on February 22, which could be pretty solid, especially after the crappy quarter they reported last November. Stock is not particularly cheap as it is trading at 20x next year’s earnings, pretty much in line with other software cos, but if company can show growth again, stock will be poised to move higher.